Clustermarket taps into GE Healthcare Life Sciences customers to reach UK Innovators
Clustermarket, the leading UK online scientific equipment sharing and booking platform, has enlisted the support of GE Healthcare’s Life Sciences business in an agreement aimed at helping innovators in the UK access specialised life sciences and biotech equipment.
“The demand for state-of-the-art instruments among early-stage ventures is rising and our mission, with the support of GE, is to enable sourcing of such equipment and services to allow innovative companies such as MediSieve to thrive,” said Johannes Solzbach, Chief Executive Officer, Clustermarket.
Introducing GE customers to the Clustermarket platform has, for example, already enabled University College London spin-out MediSieve to access to GE’s specialised Biacore T200 installed at the National Physics Laboratory. The London-based startup’s magnetic blood filtration technology has the potential to transform the treatment of blood borne diseases, and access to the Biacore instrument allowed MediSieve to carry out critical work in the understanding of interactions between antibodies and their targets.
- Novartis Social Business: Blending profit with purpose
- Top 10 healthcare innovations for 2019
- Aetna International – educating health consumers through innovation
George Frodsham, Chief Executive Officer and Founder, MediSieve said: “The Biacore T200 surface plasmon resonance system has helped us to better understand the molecular interaction occurring between an antibody and its target enabling the development of our potentially life-changing technology to advance. Clustermarket has been invaluable from the beginning in sourcing the equipment and services we need to develop our technology.”
Conor McKechnie, Chief Marketing Officer, Life Sciences, GE Healthcare said: “It is great to see our instruments being used through such an innovative arrangement to support and advance science. In this instance, an early-stage, vibrant biotech start-up has been able to access technology that would otherwise be out of its reach, delivering a new and deeper insight to help advance its research.”
By opening up access to such world-class technologies at leading UK universities and other facilities, this approach helps ensure that more government grant-funded equipment finds its way into the growing life science SME community, helping to accelerate research so that novel and potentially life-changing technologies are brought to market faster.
To further facilitate access to the right advanced technologies for the right science, GE and Clustermarket have deployed Fetch.AI’s Autonomous Economic Agents on the Clustermarket platform. Fetch agents provide personalised recommendations of specific equipment and services that may aid customers’ research based on previous requests. This helps life sciences companies find the assets they need whilst increasing bookings through the Clustermarket platform.
Rackspace surveys healthcare leaders' knowledge of tech
A new survey sponsored by Rackspace Technology has analysed how well healthcare leaders understand technology today, compared to five years ago.
Rackspace polled more than 1400 IT and non-IT decision makers in companies making over $300 million a year in six industries, one of which was healthcare.
The survey asked healthcare executives about the changing role of technology in their area, including the dangers of falling behind, their knowledge of the role of technology, and familiarity with what technology can do to the bottom-line.
The majority (90%) say their appreciation for application technology has grown over the past five years, and 88% now have a better understanding of technology than they did five years ago.
They were also asked about the ways technology helps drive corporate strategies. The survey found that:
* 62% say automation drives efficiencies
* 50% say they leverage innovative technologies like IoT and cloud native applications
* 48% say it allows greater employee collaboration
* 48% say it gives them real-time analysis/customer ‘pulse’
Among the technologies that benefit healthcare organisations the most financially i.e. generating revenue and reducing costs:
* 60% say AI/machine learning
* 61% say cybersecurity
* 56% say enterprise software
* 45% say e-commerce
* 44% say SaaS
* 41% say IoT
Almost half of the respondents (44%) say that if legacy applications aren’t modernised in the next two to three years, healthcare organisations may lose their ability to compete.
Other consequences of delaying modernising applications include:
* 56% say they wouldn’t be able to meet new regulations
* 46% say they wouldn’t be able to scale up IT to meet new demands
* 44% say customer service levels would be reduced
* 36% say they wouldn’t be able to integrate
* 33% say poor staff morale would result from inadequate systems
* 33% say there would be lost productivity
Jeff DeVerter, CTO at Rackspace Technology, commented on the research: “The results of our survey are further evidence that modernising applications through a user lens is not just a ‘nice to have’ from a customer satisfaction perspective, but also delivers a wealth of tangible, quantifiable benefits to organisations.
“Applications are a foundation of customer experience, and it is encouraging to see an increased focused and rising enthusiasm for customer experience improvements.”